Christine Durand, MD
Enriched profileAssociate Professor of Medicine and Oncology · Johns Hopkins University School of Medicine
Christine Durand is Associate Professor of Medicine and Oncology at Johns Hopkins University School of Medicine. OpenAlex indexes 265 publications with 13,018 citations (h-index 49); ClinicalTrials.gov lists 10 registered studies with this person as an investigator.
Data verified 25 Aug 2026
Overview
Updated 27 Aug 2026
Christine Durand is Associate Professor of Medicine and Oncology at Johns Hopkins University School of Medicine. The public record shows 265 publications with 13,018 citations (h-index 49), centered on HIV/AIDS drug development and treatment, Renal Transplantation Outcomes and Treatments, Hepatitis C virus research. It also documents an investigator role on 10 registered clinical trials, industry payments reported by 1 companies, 6 NIH-funded awards (2014–2026).
- Most recent indexed publication: 2026 · Clinical infectious diseases
- Top research focus: HIV/AIDS drug development and treatment
- 10 registered trials on ClinicalTrials.gov
- Open Payments reporting from 1 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 38 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 117.
Clinical & industry
trials, payments and federal fundingPublic positions
sourced statements on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hopkinsmedicine.org ↗
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 10 registered studies on ClinicalTrials.gov. The most recent:
- Expanding HOPE Liver
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
- Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney)
Sponsor: Johns Hopkins University
Industry payments
Updated 27 Aug 2026
1 company reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Gilead Sciences, Inc.Program year20251 payment$12,810openpaymentsdata.cms.gov ↗
- Gilead Sciences, Inc.Program year20241 payment$12,810openpaymentsdata.cms.gov ↗
- Gilead Sciences, Inc.Program year20231 payment$10,935openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
100%Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor43.6%Cabenuva36%Tivicay34%Dovato30%Part D<11 patientsHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor16.8%Descovy100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
6 NIH research awards on record, funded 2014–2026 per NIH RePORTER. The latest:
- HOPE Heart study: A Clinical Trial of HIV to HIV Transplantation
New York University School of Medicine
FY2026$1,717,417U01AI198070 - Kidney Transplantation from Donors with HIV: Impact on Rejection and Long-term Outcomes
Johns Hopkins University
FY2026$1,715,469U01AI177211 - A Randomized Controlled Trial of Prophylaxis with Direct-acting Antivirals for Kidney Transplantation from Hepatitis C virus-infected donor to Uninfected Recipients (PREVENT-HCV)
Johns Hopkins University
FY2026$976,602U01AI157931
Congress activity
Updated 27 Aug 2026
3 congress contributions (2017–2019) across ASCO, ASH per OpenAlex. The most recent:
- AMC075: A randomized phase II trial of vorinostat with R-EPOCH in aggressive HIV-related NHL.
ASCO Annual Meeting
ASCO2018Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Kaposi Sarcoma-Associated Herpesvirus Risk and Disease in Kidney Donors and Transplant Recipients With HIV in the United States.
Clinical infectious diseases
Article2026 - Infections After Kidney Transplantation From Donors With HIV to Recipients With HIV.
Clinical infectious diseases
Article2026 - Allograft Rejection and the Latent HIV Reservoir in Kidney Transplant Recipients with HIV.
The Journal of infectious diseases
Article2026 - Attitudes and Perceptions of Infectious Disease Providers Toward Transplantation From Living Donors With HIV to Recipients With HIV.
Clinical transplantation
Article2025 - Trends over Time in Practice and Outcomes of Lung Transplantation in Recipients With Human Immunodeficiency Virus.
Transplant infectious disease
Article2025
Most-cited works
by citation count (OpenAlex)- 01Voriconazole versus Amphotericin B for Primary Therapy of Invasive AspergillosisArticle3,306 citations2002
- 02
- 03
- 04
- 05Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutationsArticle504 citations2015
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/christine-durand-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - ResearchGate
researchgate.net/profile/Christine-Durand
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - X / Twitter
x.com/CMDurandMD
Mentions by others
where others cite or feature them- X / Twitter
twitter.com/HopkinsMedNews/status/1111311315664924672
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →twitter.com ↗ - YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
Editorial & leadership roles
journal and society appointments- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →iasusa.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →data.the-asci.org ↗
Secondary affiliations
appointments beyond the home institution- Member
Johns Hopkins Kimmel Cancer Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗ - Founder and Co-Director
Johns Hopkins University Transplant Research Center
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hopkinsmedicine.org ↗
Media & interviews
press, podcasts and appearances- Conference recording
IAS-USA 2025 Ryan White HIV/AIDS Program Clinical Conference: "HIV and Transplantation Practice and Possibilities"
2025provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →soundcloud.com ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →baltimoresun.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hopkinsmedicine.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Julie Brahmer, MD
Johns Hopkins University School of Medicine
Kenneth Pienta, MD
Johns Hopkins University School of Medicine
Michelle Petri, MD
Johns Hopkins University School of Medicine
Harry Quigley, MD
Johns Hopkins University School of Medicine